RBC Europe’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$10K Sell
2022
Q1
$28K Buy
2021
Q4
$13K Sell
2021
Q3
$58.2K Buy
2021
Q2
$77.5K Buy
2021
Q1
$20K Buy
2020
Q4
$6.12K Buy
2020
Q1
Sell
2019
Q4
$3.9K Hold
2019
Q3
$2.62K Hold
2019
Q2
$3.01K Buy
2017
Q4
Sell
2017
Q3
$10.7K Buy